At its heart, the Global CoCreation Lab is a concentrator of talent and resources working in concert on strategic health technology innovation opportunities. Our structure and programs are designed to unite Miami’s healthcare, research, and business communities with international biomedical innovation centers.

Our primary objective is to launch innovation-driven enterprises with early traction and superior product-market fit, rooted in Miami-Dade, with regional and global projection. We expect three organic and interdependent areas of impact that can contribute to stimulate, grow, and sustain an innovation ecosystem for healthcare, medicine, and biotech:

• Higher concentration of high-tech businesses and services in healthcare, medicine, and biotech, simultaneously acting as a magnet to attract, retain, and develop human talent, through knowledge and technology transfers, and opportunities for research’s impact.
• Creation (through stakeholders’ cocreation) of specialized demand that can provide early traction for startups translating health technologies into the marketplace, while improving the probabilities of securing follow on investments to scale-up.
• Development of new Miami engineering, scientific, and business leadership, with culturally adapted/grown best practices and policy to support organic connections between corporate innovation needs and the startup community, as an equitable social model to externalize and accelerate innovation.

Affinity Groups

Our co-creation methodology systematically coalesces diverse stakeholders in Affinity Groups to create new healthcare technologies and innovation-based enterprises. Affinity groups leverage medical and technology strengths across healthcare settings to improve outcomes, increase quality, and reduce cost.

Each Affinity Group comprises projects, which are led by Fellows who attract and coordinate diverse collaborators. Projects advance in the Global CoCreation Lab when they:

• Meet a strong market or regulatory trend that justifies investment
• Demonstrate viable prototype technologies
• Can engage partners in research and development

Wellness Home Integrator
Prototype of the Wellness Home as a commercial product

Medshare Home
Triage tool for lung inflammation prognosis

Itineris AI Home
AI-based, smart interoperable assistant for intelligent patient engagement and contextual plan of care management

Medshare Provider
Triage tool for lung inflamation progonosis

Itineris AI Provider
AI-based, smart interoperable assistant for intelligent patient engagement and contextual plan of care management

Annica Health
Designing novel health diagnostic wearables using movement and sound

LiveXtent 
New perfusion technology to extend donor organ life

MembraneX
Smart dialysis membrane to filter toxic particles from the bloodstream, with a personalized profile rather than one-size fits all

Toci
Developing AI technology that leverages state-of-the-art Natural Language Processing (NLP), Understanding (NLU) and Generation (NLG) techniques developed at MIT to bring deeper empathy and patient-centeredness to medicine.

Annova
Designing low-cost and easy-to-use software and hardware that connects local practitioners, clinics, and hospitals to share de-identified clinical datasets globally and collectively co-create medical AI products.

AccurePCI
Pharmacogenomics platform to predict adverse drug effects based on genetic profile

AwareMe
Detection, prediction and interventions of early depression through AI analysis of smartphones usage signatures.

FlowBio
Precision Medicine microfluidic device that mimics the blood brain barrier as a versatile platform for disease and drug screenings

Thelial
Lung inflammation (COVID-19 related) prediction through epithelial cells analysis